Myomo (MYO) Cost of Revenue (2016 - 2025)

Myomo (MYO) has reported Cost of Revenue for 10 consecutive years, with $3.6 million the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Cost of Revenue rose 61.29% year-over-year to $3.6 million; the trailing twelve-month figure through Sep 2025 stood at $13.9 million (up 84.08% YoY), and the FY2024 full-year result was $9.4 million, up 54.58% from the prior year.
• Cost of Revenue improved to $3.6 million in Q3 2025 per MYO's latest filing, from $3.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $3.6 million in Q3 2025 and bottomed at $623152.0 in Q1 2021.
• Historically, Cost of Revenue has averaged $1.8 million across 5 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue dropped 11.75% in 2023, then surged 121.4% in 2025.
• Over 5 years, Cost of Revenue stood at $909175.0 in 2021, then surged by 55.52% to $1.4 million in 2022, then climbed by 16.8% to $1.7 million in 2023, then surged by 109.1% to $3.5 million in 2024, then gained by 5.65% to $3.6 million in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $3.6 million, $3.6 million, and $3.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.